• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Chardan Capital Markets initiated coverage on Korro Bio with a new price target

    4/16/25 9:07:30 AM ET
    $KRRO
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $KRRO alert in real time by email
    Chardan Capital Markets initiated coverage of Korro Bio with a rating of Buy and set a new price target of $25.00
    Get the next $KRRO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $KRRO

    DatePrice TargetRatingAnalyst
    4/29/2025$74.00Overweight
    Cantor Fitzgerald
    4/16/2025$25.00Buy
    Chardan Capital Markets
    1/10/2025$155.00Outperform
    Oppenheimer
    10/21/2024$153.00Strong Buy
    Raymond James
    8/14/2024$180.00Outperform
    William Blair
    3/28/2024$100.00 → $115.00Buy
    H.C. Wainwright
    2/27/2024$120.00Outperform
    BMO Capital Markets
    12/4/2023$100.00Buy
    H.C. Wainwright
    More analyst ratings

    $KRRO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Mathers Edward T bought $999,992 worth of shares (17,857 units at $56.00) (SEC Form 4)

      4 - Korro Bio, Inc. (0001703647) (Issuer)

      4/24/24 5:00:19 PM ET
      $KRRO
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Florence Anthony A. Jr. bought $999,992 worth of shares (17,857 units at $56.00) (SEC Form 4)

      4 - Korro Bio, Inc. (0001703647) (Issuer)

      4/24/24 5:00:26 PM ET
      $KRRO
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Yang Rick bought $999,992 worth of shares (17,857 units at $56.00) (SEC Form 4)

      4 - Korro Bio, Inc. (0001703647) (Issuer)

      4/24/24 5:00:16 PM ET
      $KRRO
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $KRRO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Director Behbahani Ali

      4 - Korro Bio, Inc. (0001703647) (Issuer)

      6/12/25 4:40:18 PM ET
      $KRRO
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4 filed by Director Meyers Rachel

      4 - Korro Bio, Inc. (0001703647) (Issuer)

      6/12/25 4:32:03 PM ET
      $KRRO
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4 filed by Director Bermingham Nessan

      4 - Korro Bio, Inc. (0001703647) (Issuer)

      6/12/25 4:29:03 PM ET
      $KRRO
      Biotechnology: Pharmaceutical Preparations
      Health Care